Novartis verdict fallout: Patents vs patients?

PUBLISHED ON: April 6, 2013 | Duration: 50 min, 44 sec

   
loading..
After this week's Supreme Court verdict dismissing Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, we debate: Will investment in India be discouraged? And can we get affordable life-saving medication to millions?
ALSO WATCH
Novartis ruling shows India doesn't want innovation: Peter Pitts

................................ Advertisement ................................

................................ Advertisement ................................